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Abstract
Background: Patient-specific absorbed dose calculations for molecular radiotherapy
require accurate activity quantification. This is commonly derived from Single-Photon
Emission Computed Tomography (SPECT) imaging using a calibration factor relating
detected counts to known activity in a phantom insert.
Methods: A series of phantom inserts, based on the mathematical models underlying
many clinical dosimetry calculations, have been produced using 3D printing
techniques. SPECT/CT data for the phantom inserts has been used to calculate new
organ-specific calibration factors for 99mTc and 177Lu. The measured calibration factors
are compared to predicted values from calculations using a Gaussian kernel.
Results: Measured SPECT calibration factors for 3D printed organs display a clear
dependence on organ shape for 99mTc and 177Lu. The observed variation in calibration
factor is reproduced using Gaussian kernel-based calculation over two orders of
magnitude change in insert volume for 99mTc and 177Lu. These new organ-specific
calibration factors show a 24 , 11 and 8 % reduction in absorbed dose for the liver,
spleen and kidneys, respectively.
Conclusions: Non-spherical calibration factors from 3D printed phantom inserts can
significantly improve the accuracy of whole organ activity quantification for molecular
radiotherapy, providing a crucial step towards individualised activity quantification and
patient-specific dosimetry. 3D printed inserts are found to provide a cost effective and
efficient way for clinical centres to access more realistic phantom data.
Keywords: Activity quantification, SPECT, Molecular radiotherapy, 3D printing,
Absorbed dose
Background
Accurate activity quantification is essential for patient-specific absorbed dose calcu-
lations for Molecular Radiotherapy (MRT). Current activity quantification for Single-
Photon Emission Computed Tomography (SPECT), as commonly used in MRT, often
relies on camera-specific calibration factors, determined from phantom data. These
camera-specific calibrations are used to compensate for the many quantitative inaccura-
cies in SPECT imaging [1]. Calibration factors determined from physical phantom data
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are highly dependent on the specific geometry and activity distribution being consid-
ered. The geometry of phantom inserts used for SPECT activity calibration is often far
removed from both the clinical situation and the mathematical models which provide the
basis of the most common MRT dosimetry calculations. The OLINDA/EXM software
[2] applies the MIRD schema for whole organ dosimetry [3], using mathematical models
defined in [4–7], and is currently the only FDA-approved general MRT dosimetry code.
Whilst these generic organmodels do not reflect the range ofMRT patient morphologies,
they do allow dose calculations to be adapted to consider individual organ masses and
patient age and sex. As such, the ready availability of phantoms providing activity distribu-
tions which better approximate clinical MRT distributions will provide a significant step
forward towards accurate patient-specific dosimetry for all clinical centres performing
MRT.
In this work, a series of novel phantom inserts corresponding to organ models used in
common MRT dosimetry systems have been produced, based on the models described
in [4]. The inserts have been printed using fused filament modelling (3D printing) with
acrylonitrile butadiene styrene (ABS) plastic. This paper presents SPECT/CT data for
the printed inserts containing 99mTc and 177Lu in a water-filled phantom. The suitabil-
ity of ABS plastic as a tissue analogue for MRT phantom production is demonstrated
for the first time. SPECT calibration factors for 99mTc and 177Lu, corresponding to the
MIRD organ geometries defined in [4], are determined. A significant dependence on
organ shape for calibration factors is demonstrated and compared to calculated val-
ues. Finally, the influence of improved organ-specific calibration factors on clinically
representative absorbed dose calculations (using the OLINDA/EXM package) is eval-
uated. 3D printing production allows the phantom inserts to be made available [8] in
stereolithography (STL) format, which can be printed using a commercial 3D printer
or printing service. Providing access to the phantom inserts described in this work
will allow any clinical centre to accurately calibrate clinical SPECT activity quantifica-
tion for input to whole organ MRT dosimetry calculations, resulting in improved dose
calculations.
Methods
3D printed phantom inserts
The designs and final printed inserts are shown in Fig. 1. The inserts consist of shells
with 2-mm thick walls (3 mm for the larger liver model) which can be filled with a
radioisotope solution. The inserts have integrated attachment and filling ports which
can be fitted with standard M5 screw threads, allowing them to be used in a variety
of commercial phantoms. Inserts were designed based on the adult male models for
MRT dose-limiting organs as described in [4] (see Table 1 for details). Additional inserts
corresponding to age-5 and age-10 kidneys were also produced. The adult male liver
model has been extended to include two separate lobes and a small (16 ml) tumour.
The variation of the insert volumes from those described in [4] (shown in Table 1)
reflects the physical constraints of the 3D printing technique. Binary STL files of the
models, compatible with most common models of printer, are available online [8]. The
inserts used in this work were printed from ABS plastic (ABSplus - Stratasys Ltd)
with a 0.178-mm layer thickness (solid wall interior) using a Dimension Elite printer
(Stratasys Ltd).
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Fig. 1 CAD models designed from adult male mathematical models defined in [4] (top). The liver model
(right) has been extended to include a spherical tumour and separate lobes. Organ inserts printed with white
ABSplus (middle). Central slice through SPECT reconstruction of inserts containing 99mTc (bottom)
SPECT phantom data
The phantom inserts were filled with saline containing either 99mTc pertechnetate or
177Lu-Dotatate (with the activities given in Table 1) and placed individually in the cen-
tre of a water-filled elliptical phantom without activity (9.5 l, 186-mm high with 305 and
221 mm radii). The phantom was imaged in the same central position on the bed with
a fixed head radius of 25 cm for each insert to ensure a constant SPECT resolution.
Positioning both the phantom and insert centre-of-mass in the centre of the SPECT field-
of-view ensures optimal performance of CT-based attenuation correction for SPECT
Table 1 Details of phantom inserts, mathematical models volumes [4] and radioisotope activities
Organa Model volumeb Printed insert volume Activity 99mTc Activity 177Lu
(cm3) (cm3) (MBq) (MBq)
Spleen 176.0 195.26 ± 0.02 122.3 ± 0.3 639.1 ± 1.2
Pancreas 83.8 103.26 ± 0.02 110.4 ± 0.3 397.4 ± 0.7
Liver 1830.0 1577.49 ± 0.02 515.3 ± 1.2 2976.8 ± 5.6
Liver (left)c – 479.00 ± 0.02 172.4 ± 0.8 924.2 ± 4.0
Liver (right)c – 1098.49 ± 0.02 342.9 ± 0.9 2052.6 ± 3.9
Liver (tumour)c – 16.49 ± 0.02 6.4 ± 0.2 43.0 ± 0.5
Kidney 144.0 169.81 ± 0.02 125.0 ± 0.3 1024.6 ± 1.2
Kidney age 10 80.3 99.54 ± 0.02 92.5 ± 0.2 589.5 ± 0.2
Kidney age 5 55.5 64.96 ± 0.02 32.6 ± 0.1 383.9 ± 0.2
aAdult male organs unless specified
bValues from [4]
cAdditional sub compartment added to model
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reconstruction [9]. SPECT/CT data were acquired for each insert and radioisotope using
an Infinia-Hawkeye-4 SPECT/CT camera (GE Healthcare). LEHR andMEGP collimators
were used for 99mTc and 177Lu, respectively. Scans were performed using 60 views in a
step-and-shoot circular orbit (20 s per view for 99mTc and 40 s per view for 177Lu). Pro-
jection data was acquired in a matrix of 128 × 128 4.42-mm pixels for the 140±10% keV
photopeak of 99mTc and the 208±10% of 177Lu. Data was also acquired for energy win-
dows adjacent to the photopeak (99mTc 120±3% keV, 177Lu 181±3% and 236±3% keV)
allowing dual or triple energy windows scatter correction to be applied [10]. The phantom
data were reconstructed using a clinical OSEM algorithm (GE OSEM) with ten subsets
and four iterations. This reconstruction algorithm does not include collimator-detector
response (CDR) compensation, which can improve spatial resolution and reduce spill-
out of counts. It should be noted however that CDR compensation may create ringing
artefacts which change the distribution of counts within a volume of interest (VOI) [11].
The reconstruction parameters were found to provide stable quantification for all organ
VOIs for both 99mTc and 177Lu, with the total number of reconstructed counts increasing
by < 0.7 % for higher numbers of reconstruction iterations. Attenuation correction (AC)
was applied using Hawkeye CT data (140 kV, 2.5 mA) acquired as part of the scan pro-
tocol. The central slice through the SPECT reconstructions of the inserts, demonstrating
the activity distribution, is shown in Fig. 1.
Organ-specific SPECT calibration factors
Generally, a calibration factor, cf, is defined which relates the count rate (counts per sec-
ond, cps) in a reconstructed SPECT image volume-of-interest (VOI) to the total activity
(MBq) in the VOI in order to provide activity quantification of SPECT imaging for MRT
patients,
cf = countstotal activity · time =
count rate
total activity . (1)
A VOI defining each organ insert was manually outlined using the Hawkeye CT data
and transferred to the SPECT image. A corresponding calibration factor (cfvoi) for 99mTc
and 177Lu was calculated for each VOI. The total number of isotropic voxels, of size 4.42
mm (as used for the SPECT images), defining the inner volume for each VOI was also
measured. The sensitivity of a SPECT camera is system specific. Experimentally deter-
mined SPECT calibration factors are highly dependent on the choice of reconstruction
parameters, including scatter correction, attenuation correction and partial volume cor-
rections. In addition, when applying any phantom-based SPECT calibration factors to
patient data, the activity concentration outside the VOI, which varies for each patient
and organ, must also be accounted for. In order to isolate the influence of VOI shape
on calibration factor from these effects, identical reconstruction parameters and phan-
tom position were used for all scans with no background activity. This ensures that any
variation in measured calibration factors are due to the choice of phantom insert alone,
highlighting the benefits of using more representative organ geometries.
Measuring true camera sensitivity calibration factor (cftrue)
The true camera sensitivity calibration factor, cftrue, gives the SPECT camera sensitivity
(cps/MBq) when no partial volume effects are present. To determine cftrue, additional
SPECT/CT data was acquired for a 7.3-l cylindrical phantom (height 200 mm and radius
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108 mm) containing 712(1) MBq and 3551(7) MBq of 99mTc and 177Lu, respectively. The
phantom was imaged using the same acquisition and reconstruction protocols previously
described for the phantom inserts. The true calibration factor was calculated (equation 1)
from the uniform phantom data using the reconstructed total number of counts in the
SPECT field of view.
VOI calibration factor
The finite resolution of a reconstructed SPECT image causes the measured calibration
factor for a specific VOI (cfvoi) to deviate from the “true” camera sensitivity calibra-
tion factor, cftrue due to spatial blurring of the count distribution. The measured counts
detected within a VOI (countsvoi) can therefore be defined by,
countsvoi = countstrue − countsoutside (2)
where countstrue is the “true” number of counts in the VOI and countsoutside represents
counts originating from the VOI which are detected outside the VOI. For a simple geom-
etry, described by a known mathematical function, the effects of finite spatial resolution
and discritization of counts in a voxelised VOI may be considered individually. However,
obtaining an analytical solution for spatial blurring of an arbitrarily shaped volume is
often not possible. In this work, a voxelised approach, which can be applied to any VOI
and combines the effect of discretization and limited spatial resolution, is presented. For





where αi is the fraction of true events in voxel i which are located outside of the VOI
and ci is the number of true events in the voxel. The value of αi can be calculated for an
individual voxel within a VOI, centred at xi, yi and zi, by considering the convolution with
a 3D Gaussian kernel, g(x, y, z, σ), integrated over the volume of the VOI.
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where xa, xb, ya, yb, za and zb are the closest perpendicular distances to the VOI boundary
(for a voxel centred at xi, yi and zi) in the x, y and z dimensions, respectively. g(x, y, z, σ) is
defined as,
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The value of αi, and therefore cfvoi, is highly dependent on both the specific three-
dimensional geometry of a VOI and the resolution of the SPECT camera. In addition, for
voxels located on the edge of a VOI, the voxel size will define the closest perpendicular
distance to the VOI boundary. In general, the value of αi for a voxel on the perimeter
of a VOI will vary significantly according to position on the surface, whilst for centrally
located voxels, αi ∼ 0 (when the VOI is sufficiently large compared to FWHM).
For example, with a spatial resolution of 10 mm, an isotropic 4.42-mm voxel size and
no activity outside the VOI, Eq. 4 predicts αi = 0.30 (a 30 % loss in counts) for a voxel in
the centre of a face of a cubic VOI of length 300 mm. For a voxel on the centre of one
edge or corner of the VOI perimeter, αi = 0.51 (51 % loss) and 0.66 (66 % loss of counts),
respectively, and for a single cubic voxel, αi = 0.94. The corresponding values of αi for an
infinitesimal voxel size (point source) are 0.5 (centre of a face), 0.75 (edge of cube) and
0.875 (corner). In general, for a voxel on the edge of a VOI, the value of αi can be expressed
as αi(x, σ)n where n is the number of VOI edges intersected by the voxel. The spill-out
fraction from a VOI can be approximated as being proportional to areavoi/volumevoi.
When activity is present outside the VOI, then Eq. 7 has an additional spill-in compo-
nent, which is analogous to Eq. 3 but summed over all voxels containing activity outside
the VOI, increasing the value of cfvoi/cftrue.
Absorbed dose calculations
Absorbed dose calculations were performed on VOIs corresponding to the liver, spleen
and kidneys for co-registered sequential SPECT/CT images of a patient receiving 177Lu-
Dotatate therapy with the OLINDA/EXM package [2]. VOIs for these organs were
manually defined at each imaging time point on the CT images fused with the SPECT
data. The patient CT images showed no evidence of motion between SPECT and CT
acquisition or imaging artefacts at the organ edges which may affect VOI definition. Sep-
arate time-activity curves (for imaging times, 1-, 24-, 71- and 143-hr post injection) were
generated, using a calibration factor for each organ, or with standard sphere (113 ml,
27-mm radius) and cylinder calibration factors (278 ml, 44-mm diameter and 183-mm
height). The residence time (Acumulative/Ainjected), as defined by [2], for each organ was
calculated using a fit to a single exponential decay and an initial injection activity of 7448
MBq. MRT time-activity data is highly patient-specific and varies significantly for dif-
ferent organs and tumour burdens, often requiring detailed pharmacokinetic modelling
[12]. For the patient time-activity data chosen in this study, the difference in calculated
residence time for a bi-exponential fit, compared to a single exponential, was found to
be <1 %, significantly smaller than the uncertainty in Acumulative (∼12 %). Masses were
calculated from CT imaging for the liver, spleen and kidneys; otherwise, organ masses
were scaled to the total body weight of the patient.
Results
ABSmaterial properties
CT data from SPECT/CT scans of the phantom inserts were first used to measure the
CT attenuation of the ABS material. The ABS material in the inserts was found to have a
mean value of −54±13 HU. The effective density of an ABS print depends on the model
geometry and properties of the printer. The inserts produced in this work have a mean
effective density of 1.01±0.02 g/cm3, corresponding to a packing density of 0.97±0.02.
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ABS printedmaterial was found to provide a closer analogue to water (−7.4±8.7HU) than
perspex (116±9 HU) reducing the artificial boundary effect between regions of activity in
the phantom. This result demonstrates that ABS printing, the most commonly available
and affordable form of 3D printing, is a suitable technique for MRT phantom production.
Whole organ calibration factors
The measured true camera sensitivity calibration factors (cftrue) for 99mTc and 177Lu
are given in Table 2. These values were calculated from uniform phantom data using
the reconstructed total number of counts in the SPECT field of view. The ratio of the
measured calibration factor (cfvoi) to cftrue for 99mTc and 177Lu, calculated using CT-
defined VOIs outlining the phantom inserts, is shown in Fig. 2 (black squares). Data is
presented for non-spherical inserts consisting of 3D printed organ inserts, for a 278-
ml perspex cylinder and for a series of spherical perspex inserts (2 to 113 ml). The
plotted standard uncertainties include a ±1 voxel (4.42 mm) uncertainty in positioning
the VOIs.
As predicted (by Eqs. 4 and 7), the value of cfvoi/cftrue approaches 1 for the larger organ
inserts and is significantly reduced for the smaller spherical inserts. The theoretical value
of cfvoi/cftrue for a uniform activity distribution, calculated using Eq. 7 and a FWHM of
15 mm, is shown for each VOI in Fig. 2 (red circles). There is a good agreement with
the measured values of cfvoi/cftrue for the larger inserts, including the 113-ml sphere.
However, the measured values of cfvoi/cftrue is systemically larger for the smaller spherical
inserts (2–16 ml). In this paper, data is presented without scatter correction to ensure the
influence of organ shape is isolated. It should be noted however that the same tendency
in cfvoi (with a corresponding reduction in counts per MBq) is observed for both 99mTc
and 177Lu when consistent scatter correction is applied to these data (using the previously
defined scatter windows).
Absorbed dose calculations
Table 3 shows 177Lu cumulative activity and absorbed dose calculations for the liver,
spleen and kidneys using organ-specific activity calibration factors from 3D inserts (as
previously described). Values are also given for a standard spherical insert (113 ml) and
cylindrical insert (278 ml) calibration factor for comparison, which approximate the
average organ volumes in Table 1 and are commonly available to clinical centres.
Discussion
Organ-specific calibration factors
SPECT activity calibration factors measured for 3D printed organ inserts display a
clear dependence on organ shape for both 99mTc and 177Lu, see Fig. 2. For each insert,
the ratio of cfvoi to cftrue is constant for 99mTc and 177Lu, demonstrating that the
Table 2 True camera sensitivity calibration factor (cftrue) determined from reconstructed total counts
in field of view for a 7.3-l cylindrical phantom containing uniform activity
Isotope Phantom activity cftrue
(MBq) (cps/MBq)
99mTc 712 ± 1 150.49 ± 0.34
177Lu 3551 ± 7 11.74 ± 0.02
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Fig. 2 Ratio of VOI calibration factor (cfvoi) to true camera sensitivity calibration factor (cftrue), as a function of
number of voxels in VOI (nVoxels). Data is shown for phantommeasurements (black and green squares) and
corresponding calculated values (red circles) (Eq. 7). The plotted standard uncertainties include a ±1 voxel
(4.42 mm) uncertainty in positioning the VOIs. Note logarithmic scale on x-axis
shape and volume of the VOI are the main influences on relative calibration factor.
The measured values of cftrue (Table 2) reflect the gamma emission probabilities for
the 140 keV emission from the decay of 99mTc and the 208 keV emission following
the decay of 177Lu (89 and 10.4 %, respectively) and the system sensitivities at these
energies.
Figure 2 shows close agreement between the measured VOI calibration factors and the-
oretical values, as defined in Eq. 7 with a FWHM of 15 mm (σ = 6.4 mm), for insert
volumes >16 ml and for 99mTc and 177Lu. The converging value of FWHM (which will
vary with the choice of collimator, orbital distance and emission energy) for 99mTc (LEHR
collimators) and 177Lu (MEGP collimators) at a 25-cm orbital radius is consistent with
previously reported data [13].
For all insert data, discretization effects will give counts in voxels adjacent to the VOI,
analogous to background activity. This effect is negligible for large volume inserts result-
ing in good agreement with calculated values from Eq. 7. For the smaller inserts, the
Table 3 Clinically representative 177Lu MRT absorbed dose calculation using calibration factors from
3D printed organ inserts and spherical and cylindrical inserts
Organ factor Sphere factora Cylinder factorb
Acumulative Abs. Dose Acumulative Abs. dose Dosec Acumulative Abs. dose Dosec
(GBq.Hrs) (mGy) (GBq.Hrs) (mGy) (%) (GBq.Hrs) (mGy) (%)
Spleen 48.8 ± 9.2 10500 54.9 ± 10.1 11800 11.0 43.4 ± 0.8 9370 −12.1
Liver 59.8 ± 4.2 2690 78.6 ± 5.5 3540 24.0 62.1 ± 4.4 2790 3.6
Kidneys 13.9 ± 1.6 6040 15.0 ± 1.1 6570 8.1 11.9 ± 0.8 5190 −16.4
OLINDA/EXM calculations [2] using representative organ-specific time-activity curve data from clinical patient
a113-ml volume
b278-ml volume
cChanged in absorbed dose compared to using organ calibration factor
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CT-defined VOIs correspond to a relatively small number of voxels (20–180 voxels in 2–
16 ml) and so the effect is enhanced, resulting in the underestimation of the calculated
values (see Fig. 2). The inclusion of an additional component, as previously discussed
in the case of background activity outside the VOI, is required to fully reproduce the
measured values of cfvoi/cftrue below 16 ml. Compensation for this effect is particularly
important for accurate tumour activity quantification.
This work has demonstrated a clear relationship between measured whole organ cal-
ibration factors and VOI shape. The observed variation in calibration factor has been
reproduced with a simple voxel level calculation over two orders of magnitude change in
insert volume. These results highlight the potential for individualised whole organ activity
quantification, corresponding to patient organ VOIs. An alternative method for deriv-
ing whole organ calibration factors based on small VOIs placed in areas of homogeneous
activity within organs is reported in [14]. It should be noted however that this method
does not account for any inhomogeneous activity distribution within an VOI or for the
the shape of the VOI, as presented in this paper.
The close agreement between measured VOI calibration factors and theoretical val-
ues calculated using Eq. 7 shown in this current work highlights the potential to use
theoretical VOI specific calibration factors. It should be noted, however, that activity
quantification from SPECT imaging relies on a complex chain of related corrections and
calibration [1] determinations. The presence of background activity surrounding a VOI,
as seen in clinical situations, will result in variable amounts of spill-in which must be
accounted for when applying any SPECT calibration. In addition, changes to the specific
SPECT reconstruction, including scatter correction and VOI definition techniques [15],
will result in different activity calibration factors. Consequently, whilst the analysis pre-
sented in this paper has been constrained to focus on the influence of insert geometry
on SPECT calibration, the trends in calibration factor resulting from VOI shapes must be
determined for each individual SPECT system and choice of reconstruction parameters.
The use of 3D printed inserts provides a cost-effective and efficient way for clinical cen-
tres to produce phantom data for non-spherical activity distributions. Access to this data
is essential for the validation of whole organ calibration factors (and corrections based on
them) and has the potential to improve the accuracy of any SPECT quantification.
Impact on absorbed dose calculations
The representative absorbed dose calculations for 177Lu shown in Table 3 demonstrate a
significant variation in calculated dose to all organs with changing calibration factor. The
observed variations in organ-specific calibration factors from a spherical factor (as shown
in Fig 2) translate directly into a corresponding change in residence time and subsequent
absorbed dose calculation.
In particular, a 24 % reduction in calculated absorbed dose for the liver is seen when
using calibration factors from a 3D printed organ insert in comparison to a factor from
a standard 113-ml spherical insert. It should be noted that the measured value cfvoi for
the liver insert is still 20 % smaller than the true camera sensitivity factor cftrue. A cali-
bration factor (cfvoi/cftrue = 0.86) for a theoretical 1577-ml sphere, matching the volume
of the liver insert, can be calculated using Eq. 7. Applying this larger spherical factor
reduces the calculated absorbed dose for the liver to 2880 mGy. The calculated dose
is still 7 % higher than when an organ-specific factor is applied (see Table 3) showing
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that this approach does not fully account for the shape of a VOI. This highlights the
importance of using appropriate calibration factors which match both the shape and vol-
ume of a VOI. For the spleen and kidneys, a 113-ml sphere is a closer approximation
to the organ geometry; however, a reduction in organ dose of 11 and 8.1 %, respec-
tively, is observed when using organ-specific calibration factors compared to a 113-ml
spherical calibration factor. These results suggest that the accuracy of absorbed dose cal-
culations may be profoundly influenced by using these generic organ models. There is a
potential for further improvement by extending the technique presented in this paper to
patient-specific CT-based phantoms [16], providing either individualised phantom insert
measurements or a general validation for patient-specific calculations. These techniques
have the potential to provide fully individualised activity quantification which can be
further extended to provide improved sub-organ volume dosimetry. The most efficient
clinical implementation of these techniques on an individual patient basis remains to be
established.
Conclusions
This work demonstrates a novel technique which delivers improved whole organ SPECT
activity quantification and absorbed dose calculations for MRT. The inserts developed in
this work provide unique SPECT imaging data, with activity distributions matching the
underlying mathematical models for MRT dosimetry, which can be used to validate all
approaches to SPECT activity quantification. Organ-specific SPECT calibration factors
for 99mTc and 177Lu demonstrate a clear dependence on organ shape for both 99mTc and
177Lu, with a reduction in calculated absorbed dose compared to simple spherical inserts.
The results presented in this work are accurately reproduced with Gaussian kernel-based
calculations, over two orders of magnitude change in insert volume. These results high-
light the potential for individualised whole organ activity quantification, corresponding
to patient organ VOIs, to improve accuracy in whole organ dosimetry. The ability to pro-
duce MRT phantom inserts, with a reduced boundary effect between regions of activity
in the phantom, using commonly available ABS printers allows complex phantom inserts
to be made available to all clinical centres. The ability for clinical centres to test SPECT
systems with activity distributions which represent the mathematical models underlying
MIRD schema dose calculations is a crucial step in establishing validatedMRT dosimetry.
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